苦参治疗慢性乙型肝炎病毒感染的系统评价研究方案

背景 慢性乙型肝炎病毒(HBV)感染是一个严重的临床和公共卫生问题,目前尚缺乏有效的治疗措施。现有的临床资料显示苦参在治疗慢性HBV感染方面有一定的潜力。目的 系统评估苦参用于治疗慢性HBV感染的有效性和安全性。检索策略 以苦参,苦参素,苦参制剂及其商品名称和乙型肝炎,乙肝病毒,慢性携带状态为主题词,检索Cochrane肝胆病组临床试验资料库、Cochrane补充医学资料库Cochrane图书馆中心数据库、MEDLINE、EMBASE和中国生物医学光盘数据库(CBM)。手工检索了20种中医杂志,及有关学术会议论文汇编。鉴定的相关文章附录的参考文献作为补充检索。资料纳入标准:所有研究苦参冶疗慢性HBN感染的随机临床对照试验均被纳入。评价方法参照Cochrane系统评价的要求,对选择纳入的临床试验进行方法学质量的评估、数据的提取和数据的分析。

Sophorus for chronic hepatitis B virus infection: protocol of a systematic review

Background Hepatitis B is one of the major infectious diseases of mankind, and up to now, there is no effective way to handle it. Recent clinical trials have shown the potential advantages of Kurorinone an extract of Chinese herb, in treatment of chronic HBV infection. Objectives systemic-ally review the safety and efficacy of Kururinone in treatment of chronic HBV infection. Search strategy With the searching terms including Kurorinone, its products' name, hepatitis B and chronic carrier status, the trials registers of the Cochrane Hepato- Biliary Group, the Cochrane Complementary Medicine Field, and the central database of the Cochrane Library as well as MEDLINE, EMBASE and Chinese Biomedical CD Database were searched from their date of inception onward. 20 Chinese medical journals and relevant academic conference proceedings have been searched by hand. The reference lists of identified documents were checked as the complementary search. Inclusion Criteria All RCTs that tested Kurorinone for chronic HBV infection were included in this review. Method of the review According the demand of Cochrane systemic review, selection of trial for inclusion, assessment of methodological quality, data extraction and data syntheses would be conducted for each included trial.